Lemaitre Vascular (LMAT) Other Accumulated Expenses (2012 - 2026)

Lemaitre Vascular (LMAT) has reported Other Accumulated Expenses for 15 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 241.33% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 241.33% YoY), while the FY2025 annual figure was $546000.0, up 26.68% from the prior year.
• Other Accumulated Expenses improved to $1.3 million in Q1 2026 per LMAT's latest filing, from $546000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $6.1 million in Q2 2022 and bottomed at $119000.0 in Q3 2022.
• Historically, Other Accumulated Expenses has averaged $1.0 million across 5 years, with a median of $431000.0 in 2024.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses slumped 97.78% — and 2026, when it surged 241.33%.
• Lemaitre Vascular's Other Accumulated Expenses stood at $252000.0 in 2022, then soared by 58.73% to $400000.0 in 2023, then rose by 7.75% to $431000.0 in 2024, then gained by 26.68% to $546000.0 in 2025, then surged by 145.05% to $1.3 million in 2026.
• Business Quant data shows LMAT's Other Accumulated Expenses at $1.3 million in Q1 2026, $546000.0 in Q4 2025, and $438000.0 in Q3 2025.